|
|
|
|
|
76.
14280 Accesses
|
Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases
Nathan J Zvaifler Arthritis Research & Therapy 2006, 8:210 (9 May 2006)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
77.
14235 Accesses
|
Biology of RANK, RANKL, and osteoprotegerin
Brendan F Boyce, Lianping Xing Arthritis Research & Therapy 2007, 9(Suppl 1):S1 (29 June 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
78.
14208 Accesses
|
Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1
Helena d'Elia, Lars-Åke Mattsson, Claes Ohlsson, Elisabeth Nordborg, Hans Carlsten Arthritis Res Ther 2003, 5:R202-R209 (1 May 2003)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
79.
14074 Accesses
|
A pilot study of IL-1 inhibition by anakinra in acute gout
Alexander So, Thibaut De Smedt, Sylvie Revaz, Jürg Tschopp Arthritis Research & Therapy 2007, 9:R28 (12 March 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
In a pilot study on 10 patients with gouty arthritis, IL-1 blockade with anakinra gave rapid relief of inflammatory symptoms where standard treatments had failed or were not tolerated.
|
|
|
80.
14050 Accesses
|
Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia
Manuel Martinez-Lavin Arthritis Research & Therapy 2007, 9:216 (6 July 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
81.
14032 Accesses
|
Gout. Novel therapies for treatment of gout and hyperuricemia
Robert Terkeltaub Arthritis Research & Therapy 2009, 11:236 (23 July 2009)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
82.
14000 Accesses
|
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset
Raphaela Goldbach-Mansky, Jennifer Lee, Angela McCoy, Joseph Hoxworth, Cheryl Yarboro, Josef S Smolen, Günter Steiner, Antony Rosen, Cindy Zhang, Henri A Ménard, Zhi Jie Zhou, Timo Palosuo, Walther J Van Venrooij, Ronald L Wilder, John H Klippel, H Ralph Schumacher, Hani S El-Gabalawy Arthritis Res 2000, 2:236-243 (31 March 2000)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
83.
13981 Accesses
|
Oxidation in rheumatoid arthritis
Carol A Hitchon, Hani S El-Gabalawy Arthritis Res Ther 2004, 6:265-278 (13 October 2004)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
84.
13974 Accesses
|
Does a positive anti-CCP test identify a distinct arthritis entity?
Thomas Skogh Arthritis Research & Therapy 2005, 7:230-232 (16 September 2005)
Abstract | Full text | PDF
| PubMed
|
|
|
85.
13954 Accesses
|
Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management
Flavia V Castelino, John Varga Arthritis Research & Therapy 2010, 12:213 (23 August 2010)
Abstract | Full text | PDF
| PubMed
|
|
|
86.
13705 Accesses
|
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Michael A Becker, H Ralph Schumacher, Luis R Espinoza, Alvin F Wells, Patricia MacDonald, Eric Lloyd, Christopher Lademacher Arthritis Research & Therapy 2010, 12:R63 (6 April 2010)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
87.
13651 Accesses
|
Identification of blood biomarkers of rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model
Jianyong Shou, Christopher M Bull, Li Li, Hui-Rong Qian, Tao Wei, Shuang Luo, Douglas Perkins, Patricia J Solenberg, Seng-Lai Tan, Xin-Yi Chen, Neal W Roehm, Jeffrey A Wolos, Jude E Onyia Arthritis Research & Therapy 2006, 8:R28 (10 January 2006)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
88.
13627 Accesses
|
Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period
Juan J Gomez-Reino, Loreto Carmona, the BIOBADASER Group Arthritis Research & Therapy 2006, 8:R29 (6 January 2006)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
89.
13610 Accesses
|
Perspectives for TNF-α-targeting therapies
Hanns-Martin Lorenz, Joachim R Kalden Arthritis Res 2002, 4(Suppl 3):S17-S24 (9 May 2002)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
90.
13371 Accesses
|
Angiogenesis in rheumatoid arthritis
Ewa M Paleolog Arthritis Res 2002, 4(Suppl 3):S81-S90 (9 May 2002)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
91.
13357 Accesses
|
The life cycle of chondrocytes in the developing skeleton
Lillian Shum, Glen Nuckolls Arthritis Res 2002, 4:94-106 (8 November 2001)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
92.
13244 Accesses
|
The evolving clinical profile of abatacept (CTLA4–Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritis
Eric M Ruderman, Richard M Pope Arthritis Research & Therapy 2005, 7(Suppl 2):S21-S25 (16 March 2005)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
93.
13166 Accesses
|
Collagen-induced arthritis in C57BL/6 mice is associated with a robust and sustained T-cell response to type II collagen
Julia J Inglis, Gabriel Criado, Mino Medghalchi, Melanie Andrews, Ann Sandison, Marc Feldmann, Richard O Williams Arthritis Research & Therapy 2007, 9:R113 (29 October 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
C57BL/6 mice may be useful for testing new therapeutics, particularly those directed against T cells, and investigating the action of current therapies in rheumatoid arthritis.
|
|
|
94.
13067 Accesses
|
Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells
Kutty Nandakumar, Johan Bäcklund, Mikael Vestberg, Rikard Holmdahl Arthritis Res Ther 2004, 6:R544-R550 (23 September 2004)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
95.
13011 Accesses
|
Forced mobilization accelerates pathogenesis: characterization of a preclinical surgical model of osteoarthritis
C Thomas G Appleton, David D McErlain, Vasek Pitelka, Neil Schwartz, Suzanne M Bernier, James L Henry, David W Holdsworth, Frank Beier Arthritis Research & Therapy 2007, 9:R13 (6 February 2007)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
96.
13010 Accesses
|
Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides
Merete Pedersen, Søren Jacobsen, Mette Klarlund, Bo V Pedersen, Allan Wiik, Jan Wohlfahrt, Morten Frisch Arthritis Research & Therapy 2006, 8:R133 (27 July 2006)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
97.
13001 Accesses
|
Rheumatic Diseases in China
Qing Zeng, Ren Chen, John Darmawan, Zheng Xiao, Su Chen, Richard Wigley, Shun Le Chen, Nai Zhang Arthritis Research & Therapy 2008, 10:R17 (31 January 2008)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
A large population study found that the incidence of certain rheumatic diseases in China is becoming more like that of Western countries, but different joints are affected compared to Caucasian populations.
|
|
|
98.
12992 Accesses
|
Epstein–Barr virus and rheumatoid arthritis: is there a link?
Karen H Costenbader, Elizabeth W Karlson Arthritis Research & Therapy 2006, 8:204 (16 January 2006)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
99.
12949 Accesses
|
Autoantibodies in rheumatoid arthritis and their clinical significance
Günter Steiner, Josef Smolen Arthritis Res 2002, 4(Suppl 2):S1-S5 (26 April 2002)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
|
|
100.
12925 Accesses
|
Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study
Jacques Tebib, Xavier Mariette, Pierre Bourgeois, René-Marc Flipo, Philippe Gaudin, Xavier Le Loët, Paul Gineste, Laurent Guy, Colin D Mansfield, Alain Moussy, Patrice Dubreuil, Olivier Hermine, Jean Sibilia Arthritis Research & Therapy 2009, 11:R95 (23 June 2009)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
A small clinical trial has shown masitinib to be generally well tolerated and effective in the treatment of rheumatoid arthritis, indicating the need for further placebo-controlled studies.
|